William Aird: Anemia of Inflammation Not Just a Trade-Off but a Possible Compensation
William Aird, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:
”Anemia of inflammation: trade – off or adaptation?
We usually think of anemia of inflammation as a cost.
Iron is sequestered to limit microbial growth, and red cell production falls as a consequence.
But there may be another way to look at it.
The acute phase response increases plasma viscosity, driven in part by fibrinogen.
At the same time, hematocrit falls.
Since hematocrit is a major determinant of whole-blood viscosity, even a modest reduction may offset the rheologic effects of inflammation.
In other words:
- Inflammation thickens the plasma.
- Anemia thins the suspension.
Two observations are at least consistent with this idea:
- In critical care, restrictive transfusion strategies (hemoglobin ~7 g/dL) perform as well as, or better than, more liberal approaches.
- And in anemia of inflammation, hemoglobin levels tend to plateau rather than fall indefinitely, often remaining in the 7–10 g/dL range unless another process is present.
There appears to be a floor.
Not necessarily just a trade-off.
Possibly a compensation.”
Other posts featuring William Aird on Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention